COVID-19 & B-cell lymphoproliferative diseases

COVID-19 & B-cell lymphoproliferative diseases

European Hematology Association

European Hematology Association
Koninginnegracht 12b, 2514 AA - The Hague, The Netherlands


01 Hour



Course Overview

EHA is hosting a series of webinars focused on the care of hematology patients during the COVID-19 crisis. Each week, we will be collaborating with renowned hematology professionals, who will be sharing their experiences from various perspectives and addressing key questions.


Webinar Series: Session 02 (COVID-19 & B-cell lymphoproliferative diseases) - The Implications of Treatments for B-cell Lymphoproliferative Diseases and the Immune Response to COVID-19 Infection.

Featuring an expert panel from China, Italy and Germany, this webinar is focused on the implications of treatments for B-cell lymphoproliferative diseases and the immune response to COVID-19 infection.

Topics covered include:
•Immune response in patients with B-cell lymphoproliferative diseases 
•Therapies for B-cell lymphoproliferative diseases and the effect on immune response 
•Risk of COVID-19 infection in patients B-cell lymphoproliferative diseases

Tune in and gain some interesting insights from 3 experts, who will be sharing their personal experiences and opinions on the local situations they see, relating to COVID-19 and B-cell Lymphoproliferative Diseases.

Speaker panel:
•Prof Jianfeng Zhou (Tongji hospital, Wuhan, Hubei, China)
•Prof Gianluca Gaidano (University of Eastern Piedmont, Novara, Italy)
•Prof Dr Hermann Einsele (University Hospital Würzburg, Würzburg, Germany)

Note: The content discussed during this webinar is based on the personal experiences & opinions of the speakers. No general, evidence-based guidance can be derived from this discussion.

Coming session Starts May 07, 2020
Ends May 06, 2021